Development and Use of Trademarks. Licensee shall have the sole right to determine the Trademarks to be used with respect to the Exploitation of the Licensed Product on a worldwide basis, provided that the product labeling and promotional materials disclose that the Licensed Product are delivered using the Licensed Process and include the Licensed Trademarks.
Development and Use of Trademarks. Myriad shall have the sole right to determine the Trademarks to be used with respect to the development and commercialization of the Licensed Compound and the Licensed Product on a worldwide basis. Nothing in this Agreement shall be construed as granting Myriad any rights in Trademarks owned or controlled by Licensor or LLUMC.
Development and Use of Trademarks. Emergent shall have the sole right to determine the Trademarks to be used with respect to the Exploitation of Licensed Products and any and all Improvements thereto. Without the prior express written permission of HPA, Emergent shall not use, and shall not permit its Affiliates to use, the name of HPA or any of its Affiliates, or any Trademarks that is confusingly similar to, misleading or deceptive with respect to, or that dilutes any of the Trademarks owned, controlled or used by HPA or its Affiliates. Without the prior express written permission of Emergent, HPA shall not, and shall not permit its Affiliates to use the name of Emergent or any of its Affiliates, or any Trademark that is confusingly similar to, misleading or deceptive with respect to, or that dilutes any of the Trademarks owned, controlled or used by Emergent or any of its Affiliates.
Development and Use of Trademarks. Emergent shall have the sole right to select the trademarks to be used with respect to the commercialization of the Licensed Products. Without the express permission of Emergent, Aridis shall not, and shall not permit its Affiliates to use in their respective businesses, any trademark that is confusingly similar to, misleading or deceptive with respect to, or that dilutes any such trademark selected by Emergent, or any part of such trademarks.
Development and Use of Trademarks sanofi pasteur shall have the sole right, in its sole discretion (but in consultation with Emergent) to determine the Trademarks to be used with respect to any Product throughout the Territory (such Trademarks, the “Product Trademarks”); provided however, that sanofi pasteur shall not, and shall not permit its Affiliates, to use in their respective businesses, any Trademark that is confusingly similar to, misleading or deceptive with respect to, or that dilutes any of the Trademarks used by Emergent or its Affiliates in their respective businesses.
Development and Use of Trademarks. Larasan shall have the sole right to determine the Trademarks to be used with respect to the Exploitation of the Licensed Product on a worldwide basis. As may be permitted under Applicable Law product labeling and promotional materials shall disclose, in wording as exemplified in Schedule "A", that the Licensed Product(s) are manufactured for Larasan by or under license from IntelliPharmaCeutics in accordance with a licensed Technology as designated by a Licensed Trademark.
Development and Use of Trademarks. The JCC shall select all Combination Product Trademarks, which shall be owned by the JV. Subject to Applicable Law, the JV shall include a Trademark and the name of each of Gilead Parent and BMS Parent on the labeling, packaging and advertising materials for the Combination Product in the Territory. The JV shall comply with all notice and marking requirements of applicable intellectual property law for the protection and enforcement of the Trademarks of the JV, Gilead and BMS, unless such notice and marking requirements are not commercially reasonable under the circumstances.
Development and Use of Trademarks. Millennium shall have the sole right to determine the Trademarks to be used with respect to the development and commercialization of the Licensed Products or Diagnostic Products on a worldwide basis. BZL shall not, and shall not permit its Affiliates to use in their respective businesses, any Trademark that is confusingly similar to, misleading or deceptive with respect to, or that dilutes any Trademark used to identify or distinguish the Licensed Products or Diagnostic Products.
Development and Use of Trademarks. The applicable Commercialization Committee shall select all Combination Product Trademarks for use in each country in the Territory, which shall be owned by the JV. Subject to Applicable Law, the JV shall include a Trademark and the name of each of Gilead Parent and BMS Parent on the labeling, packaging and advertising materials for the Combination Product in the Territory. The JV shall comply with all notice and marking requirements of applicable intellectual property law for the protection and enforcement of the Trademarks of the JV, Gilead and BMS, unless such notice and marking requirements are not commercially reasonable under the circumstances.
Development and Use of Trademarks. W-X shall develop all Product Trademarks. Unigene shall not, and shall not permit its Affiliates or licensees to, use in their respective businesses any trade name, trademark or other designation which is similar to or substantially similar to any of the Product Trademarks, or which so nearly resembles any of them as to be likely to cause deception or confusion.
